Vibrant partnerships have been created to accelerate product development of new vaccines, drugs, and diagnostics.
With an annual budget of more than $3 million and 27 full-time employees, about 20 gallery spaces housing six-month-long temporary exhibitions on a variety of esoteric subjects like Japanese pottery and platform shoes, an Aviation Museum dedicated to commercial air travel and a vibrant commissioning partnership with the San Francisco Arts Commission, SFO is home to a world-class art collection.
The next decade might have brought more misery for the once-vibrant Washington-Islamabad partnership had it not been for the rise of Al Qaeda.
At a state and national level, she has built effective and vibrant coalitions, including partnerships with unions, the faith community, political and community organizations, and the broader LGBT community.
In answer to the question of how academic institutions will meet medical education needs and public health challenges of the 21st century, a strong, vibrant, and sustained community partnership has been developed to teach public health, address community public health needs, and develop health policy to sustain these improvements, all with a practical approach.
Ms. Barabas, who has been married to her executive producer for 35 years, said, "Creative partnerships make for vibrant marriages".
"Relativity has deep and growing ties to China, one of the world's most dynamic and vibrant film markets, and the partnerships we announced today will further strengthen the robust foundation we have built in China," Ryan Kavanaugh, chief executive of Relativity, said in a statement.
As the president of the National Park Foundation, I am acutely aware that as we celebrate this incredible milestone, we must also remember that the grand legacy of America's national parks and their future are dependent on vibrant and robust public-private partnerships.
A vibrant research program has created partnerships with a number of international research institutions worldwide.
This 'alternative' universe may currently seem a long way off: a vibrant clinical-trial culture, public-private partnerships, pathogenetic- and structure-led drug design, efficient drug development pipelines, biomarker-defined treatment protocols enabling personalization of medicine, and a bench-to-approval transit time of less than ten years.
